SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-22-006851
Filing Date
2022-10-12
Accepted
2022-10-12 17:03:40
Documents
1
Period of Report
2022-10-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2985
  Complete submission text file 0001683168-22-006851.txt   4397
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address
White Chad Norman (Reporting) CIK: 0001949607 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33216 | Film No.: 221307354